Factors influencing uptake of pre-exposure prophylaxis: some qualitative insights from an intervention study of men who have sex with men in China

被引:23
作者
Liu, Chunxing [1 ,2 ]
Ding, Yingying [1 ,2 ]
Ning, Zhen [3 ]
Gao, Meiyang [1 ,2 ]
Liu, Xing [1 ,2 ]
Wong, Frank Y. [1 ,2 ,4 ]
He, Na [1 ,2 ,5 ]
机构
[1] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200032, Peoples R China
[3] Shanghai Ctr Dis Control & Prevent, Shanghai 200336, Peoples R China
[4] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96813 USA
[5] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai 200032, Peoples R China
关键词
tenofovir disoproxil fumarate; biomedical approach; HIV prevention; PHASE-3; TRIAL; DOUBLE-BLIND; HIV; RISK; PREVENTION; PREP; ACCEPTABILITY; DISCLOSURE; TENOFOVIR; ATTITUDES;
D O I
10.1071/SH17075
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Pre-exposure prophylaxis (PrEP) is a biomedical approach for preventing the acquisition of HIV in populations at substantial risk for HIV. However, its uptake among men who have sex with men (MSM) is low in China. The study aimed to identify factors that might influence MSM's uptake and use of PrEP. Methods: In-depth interviews were conducted with 32 self-identified MSM from a PrEP intervention study evaluating daily oral tenofovir disoproxil fumarate (TDF) to prevent HIV infection. Of these men, 11 were presently using the 'TDF' group; 8 from the 'change-over' group (i.e. initially used PrEP but subsequently quitted); and 13 from the non-user group. Data were analysed using thematic approach. Results: Perception of low HIV risk, mistrust of the national PrEP program, and concerns of side effects were the main reasons for not wanting to use PrEP. Also, lack of main sexual partner's support, difficulties in adhering to the daily TDF regimen, and the inconvenient schedules in securing the medicine were the major reasons for not wanting to use or quitting the use of PrEP. On the other hand, perceived high HIV risk, beliefs in efficacy of PrEP, and worries of transmitting HIV to families were the major motives for PrEP uptake. Conclusions: Findings suggest that PrEP implementation strategies should first address issues including but not limited to accurate self-assessment of HIV risk, mistrust and limited knowledge about medical trials and PrEP, and ease of accessing PrEP.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 27 条
[1]  
[Anonymous], 2015, CHIN AIDS RESP PROGR
[2]   Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIV [J].
Auerbach, Judith D. ;
Kinsky, Suzanne ;
Brown, Gina ;
Charles, Vignetta .
AIDS PATIENT CARE AND STDS, 2015, 29 (02) :102-110
[3]   Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial [J].
Baeten, Jared M. ;
Donnell, Deborah ;
Mugo, Nelly R. ;
Ndase, Patrick ;
Thomas, Katherine K. ;
Campbell, James D. ;
Wangisi, Jonathan ;
Tappero, Jordan W. ;
Bukusi, Elizabeth A. ;
Cohen, Craig R. ;
Katabira, Elly ;
Ronald, Allan ;
Tumwesigye, Elioda ;
Were, Edwin ;
Fife, Kenneth H. ;
Kiarie, James ;
Farquhar, Carey ;
John-Stewart, Grace ;
Kidoguchi, Lara ;
Coombs, Robert W. ;
Hendrix, Craig ;
Marzinke, Mark A. ;
Frenkel, Lisa ;
Haberer, Jessica E. ;
Bangsberg, David ;
Celum, Connie .
LANCET INFECTIOUS DISEASES, 2014, 14 (11) :1055-1064
[4]   Are Centers for Disease Control and Prevention Guidelines for Preexposure Prophylaxis Specific Enough? Formulation of a Personalized HIV Risk Score for Pre-Exposure Prophylaxis Initiation [J].
Beymer, Matthew R. ;
Weiss, Robert E. ;
Sugar, Catherine A. ;
Bourque, Linda B. ;
Gee, Gilbert C. ;
Morisky, Donald E. ;
Shu, Suzanne B. ;
Javanbakht, Marjan ;
Bolan, Robert K. .
SEXUALLY TRANSMITTED DISEASES, 2017, 44 (01) :49-57
[5]   The "Safe Sex" Conundrum: Anticipated Stigma From Sexual Partners as a Barrier to PrEP Use Among Substance Using MSM Engaging in Transactional Sex [J].
Biello, Katie B. ;
Oldenburg, Catherine E. ;
Mitty, Jennifer A. ;
Closson, Elizabeth F. ;
Mayer, Kenneth H. ;
Safren, Steven A. ;
Mimiaga, Matthew J. .
AIDS AND BEHAVIOR, 2017, 21 (01) :300-306
[6]   Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation [J].
Chakrapani, Venkatesan ;
Newman, Peter A. ;
Shunmugam, Murali ;
Mengle, Shruta ;
Varghese, Jarvis ;
Nelson, Ruban ;
Bharat, Shalini .
AIDS PATIENT CARE AND STDS, 2015, 29 (10) :569-577
[7]   Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial [J].
Choopanya, Kachit ;
Martin, Michael ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Kitisin, Praphan ;
Natrujirote, Pitinan ;
Kittimunkong, Somyot ;
Chuachoowong, Rutt ;
Gvetadze, Roman J. ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Curlin, Marcel E. ;
Hendrix, Craig W. ;
Vanichseni, Suphak .
LANCET, 2013, 381 (9883) :2083-2090
[8]   Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai, China [J].
Ding, Yingying ;
Yan, Huamei ;
Ning, Zhen ;
Cai, Xiaofeng ;
Yang, Yin ;
Pan, Rong ;
Zhou, Yanqiu ;
Zheng, Huang ;
Gao, Meiyang ;
Rou, Keming ;
Wu, Zunyou ;
He, Na .
BIOSCIENCE TRENDS, 2016, 10 (02) :113-119
[9]   Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among Black men who have sex with men attending a community event [J].
Eaton, Lisa A. ;
Driffin, Daniel D. ;
Smith, Harlan ;
Conway-Washington, Christopher ;
White, Denise ;
Cherry, Chauncey .
SEXUAL HEALTH, 2014, 11 (03) :244-251
[10]   Effectiveness and safety of oral HIV preexposure prophylaxis for all populations [J].
Fonner, Virginia A. ;
Dalglish, Sarah L. ;
Kennedy, Caitlin E. ;
Baggaley, Rachel ;
O'Reilly, Kevin R. ;
Koechlin, Florence M. ;
Rodolph, Michelle ;
Hodges-Mameletzis, Ioannis ;
Grant, Robert M. .
AIDS, 2016, 30 (12) :1973-1983